Enable Injections
Cincinnati, US · Delaware corporation · 6 known investors
Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases. The company serves healthcare providers, payers, and patients by offering a mechanical hands-free alternative to intravenous treatment.
Founders & leadership
MH
Mike HoovenChairman, President and CEO
JR
John RiceDirector
TF
Timothy FlahertyExecutive Officer
SS
Simone SongDirector
KR
Karen RobardsDirector
RJ
Richard J D'AugustineDirector
NR
Norman R. WeldonDirector
Investors · 6
Competitors · 8
by search overlapDiabetes Prevention Program82 shared keywords
Dervan et al49 shared keywords
Healthline38 shared keywordsHealthline publishes medically reviewed health and wellness content for general consumers, drawing on a network of medical reviewers. It operates as a consumer health media and information platform.
visit www.bd.com31 shared keywordsBD (Becton, Dickinson and Company) develops medical technology and solutions used across healthcare settings, including devices and products supporting emergency medications and patient care. It serves hospitals, clinicians, and other healthcare providers in the broader medical device and health technology industry.
ResearchGate30 shared keywords
Cleveland Clinic, 202224 shared keywordsCleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education. The organization offers services ranging from primary care and virtual visits to specialized treatment, clinical trials, and advanced medical research.
Ziprecruiter23 shared keywords
Quizlet22 shared keywords
Companies competing with Enable Injections for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$30MraisedJan 2026 · 1 investors · Other Health CareRule 506(b)
▶$30MraisedJan 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jim CollinsDirector
- Simone SongDirector
- Richard J. D'AugustineDirector
- John RiceDirector
- David KroekelExecutive Officer
- John DeFordDirector
- Matt HuddlestonExecutive Officer
- Timothy FlahertyExecutive Officer
- Beckie RobertsonDirector
- Michael D. HoovenExecutive Officer, Director
- Erik FalkDirector
- Nigel SheailDirector
- Vickie CappsDirector
- Offering amount
- $30M
- Amount sold
- $30M
- Minimum investment
- $1
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$150MraisedFeb 2022 · 22 investors · Other Health CareRule 506(b)
▶$150MraisedFeb 2022 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John RiceDirector
- Timothy FlahertyExecutive Officer
- Michael D. HoovenExecutive Officer, Director
- Simone SongDirector
- Karen RobardsDirector
- Richard J D'AugustineDirector
- Norman R. WeldonDirector
- Offering amount
- $215M
- Amount sold
- $150M
- Minimum investment
- $1
- Sales commissions
- $8.3M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.7MraisedOct 2018 · 15 investors · Other Health CareRule 506(b)
▶$30.7MraisedOct 2018 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard D'AugustineDirector
- Timothy FlahertyExecutive Officer
- Mark A. CollarDirector
- Michael D. HoovenExecutive Officer, Director
- Norman WeldonDirector
- John RiceDirector
- Daniel von AllmenDirector
- Simone SongDirector
- Susan SpiesExecutive Officer
- Offering amount
- $50M
- Amount sold
- $30.7M
- Minimum investment
- $1
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedNov 2016 · 1 investors · Other Health CareRule 506(b)
▶$25MraisedNov 2016 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Susan SpiesExecutive Officer
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22.9KraisedAug 2016 · 1 investors · Other Health Care
▶$22.9KraisedAug 2016 · 1 investors · Other Health Care
Officers, directors & promoters on the filing
- Susan SpiesExecutive Officer
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Offering amount
- $22.9K
- Amount sold
- $22.9K
- First sale
- Jun 2014
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 04
▶$2MraisedAug 2016 · 13 investors · Other Health CareRule 506(b)
▶$2MraisedAug 2016 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Susan SpiesExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $25K
- First sale
- May 2012
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$5MraisedAug 2016 · 19 investors · Other Health CareRule 506(b)
▶$5MraisedAug 2016 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Susan SpiesExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Jun 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$100KofferedAug 2016 · Other Health CareRule 506(b)
▶$100KofferedAug 2016 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Susan SpiesExecutive Officer
- Michael HoovenExecutive Officer
- Timothy FlahertyExecutive Officer
- Offering amount
- $100K
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.